< ¸ðÁý³»¿ë >
1. ¸ðÁýȸ»ç : ¹ÙÀÌ¿À±â¾÷(±¹³»ÄÚ½º´Úµî·Ï±â¾÷)
2. ¸ðÁýºÎ¼ : CMC QCÆ÷Áö¼Ç(°úÀå~ºÎÀå±Þ)
3. ´ã´çÁ÷¹« : CMC QC/QA (½Å¾à °³¹ß °úÁ¤ Áß¿¡ ÇÊ¿äÇÑCMC QC/QA±âº» ¾÷¹«)
4. ´ã´ç¾÷¹« :
¤· ¹èÄ¡ ±â·Ï ¹× °ËÁõ ¹®¼ °ËÅä
l GMP ±âÁØ¿¡ ¸Â´Â ¹èÄ¡ ±â·Ï ¹× °ËÁõ ¹®¼ °ËÅä ¹× È®ÀÎ.
¤· IND ½Åû ¹®¼ ¹× CTD ¹®¼ °ü¸®
l Investigational New Drug(IND) ½Åû ¹®¼ÀÇ Á¤È®ÇÑ °ü¸®.
l Common Technical Document(CTD) Á¦Ãâ ¹× ¾÷µ¥ÀÌÆ® °ü¸®.
l CMC development, IMPD documentation, ICH guideline
¤· ±ÔÁ¦ Áؼö ¹× ±ÔÁ¦±â°ü °Ë»ç ´ëÀÀ(FDA,MFDS)
l ±ÔÁ¦ ±â°ü °Ë»ç ¹× ´ëÀÀÀ» À§ÇÑ ±ÔÁ¦ Áؼö º¸Àå.
l ±ÔÁ¦ °¨»ç ¹× °Ë»ç Áغñ °ü¸®.
¤· ǰÁú°ü¸®½Ã½ºÅÛ(QMS)¿î¿µ,¹× °ü¸®
l SOPÀÛ¼º,°³Á¤ ¹× °ü¸®
l SOP±³À° ½Ç½Ã,½Ç»ç °ü¸® ¹× ±ÔÁ¤ Áؼö È®º¸
l ÀÏÅ»°ü¸®,º¯°æ°ü¸®,OOS(±Ô°Ý¿Ü)°ü¸®,½ÃÁ¤ ¹× ¿¹¹æÁ¶Ä¡(CAPA),°ø±Þ¾÷ü °¨»ç°ü¸®
¤· µ¥ÀÌÅÍ ¹«°á¼º ¿î¿µ °ü¸® ¹× °³¼±
l µ¥ÀÌÅÍ ¹«°á¼º ¿î¿µÀ» °ü¸®Çϰí, µ¥ÀÌÅÍ Ç°Áú °³¼±À» À§ÇÑ È°µ¿ ÁÖµµ.
5. Çз : ´ëÁ¹ÀÌ»ó
6. Àü°ø : ¾àÇÐ,ÈÇÐ,»ý¹°Çаè¿
7. ÇÊ¿ä°æ·Â : CMC/QC/QAÆ÷ÇÔ 5³âÀÌ»ó °æÇè
8. ÀÚ°Ý»çÇ× : ¿µ¾î ÀÇ»ç¼ÒÅë Çʼö
±ÔÁ¦ ¿ä±¸»çÇ×, SOP ¹× ǰÁú °ü¸® ÇÁ·Î¼¼½º¿¡ ´ëÇÑ ÀÌÇØ.
¿ì¼öÇÑ Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Á¶Á÷ ´É·Â.
- ¿µ¾îȸȴɷÂ(±Û·Î¹ú ÆÀ ¹× ±ÔÁ¦±â°ü°úÀÇ È¿°úÀûÀÎ ¼ÒÅëÀ» À§ÇÑ
¿ì¼öÇÑ ¿µ¾î ±¸»ç ´É·Â
CDMO¿ÍÀÇ Çù·Â °æÇè ¿ì´ë
9. ¿ì´ë»çÇ× : Experience of cooperation with CDMO
10.º¸À¯±â¼ú :
Analytical Methods Development, Validation, Qualification
Analytical Chemistry and Assay Development
Method Technology Transfer
Final DP Batch Release testing and Stability Studies
Reference Standard Characterization
Test Item Specification
HPLC, LC-MS, GC, NMR
GMP, GLP, GDP, CRO
Site Audit (USA, Netherlands, China)
Deviation Investigation, CAPA
Sterility Test, Endotoxin, Environment Monitoring
DP Stability test Prolongation Statistics (JMP software)
11. ¿¬ ºÀ : ÇùÀÇ
12. ±Ù¹«Áö : ¼¿ï Áß±¸ À»Áö·Î